STRO
STRO
NASDAQ · Biotechnology

Sutro Biopharma Inc

$16.03
+0.05 (+0.31%)
As of Sep 28, 10:20 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 1 5%
Sell 1 5%
Price Target
Analyst Price Target -42.5% upside
Low Target $5.69
Average Target $9.21
High Target $10.08
Current Price $16.03
Current
$16.03
Target
$9.21
$5.69 $9.21 avg $10.08
Scenario Analysis
Bear Case
$5.69
-64.5%
Low target
Base Case
$9.21
-42.5%
Avg target
Bull Case
$10.08
+-37.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$43.85
-63.4% from high
52-Week Low
$7.15
+124.2% from low
Target vs 52W High
$9.21
-79.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%